Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    15771580 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
Condition: Non-Small Cell Lung Cancer
Intervention: Other: Evaluation of PD-1/PDL-1 expression.
2 Not yet recruiting A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Conditions: Breast Cancer;   Chest Wall Disease
Interventions: Drug: Carboplatin, Pembrolizumab;   Drug: Carboplatin
3 Unknown  Latency in Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol

Study has passed its completion date and status has not been verified in more than two years.